Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03FGM
|
||||
| Former ID |
DNC006824
|
||||
| Drug Name |
3-(2-phenyl-2-(piperazin-1-yl)ethyl)benzamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H23N3O
|
||||
| Canonical SMILES |
C1CN(CCN1)C(CC2=CC=CC(=C2)C(=O)N)C3=CC=CC=C3
|
||||
| InChI |
1S/C19H23N3O/c20-19(23)17-8-4-5-15(13-17)14-18(16-6-2-1-3-7-16)22-11-9-21-10-12-22/h1-8,13,18,21H,9-12,14H2,(H2,20,23)
|
||||
| InChIKey |
AGCDRDCNYZHHKS-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent serotonin transporter | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Serotonergic synapse | ||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | 5HT1 type receptor mediated signaling pathway | ||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| WikiPathways | Monoamine Transport | ||||
| SIDS Susceptibility Pathways | |||||
| NRF2 pathway | |||||
| Synaptic Vesicle Pathway | |||||
| Serotonin Transporter Activity | |||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2006 Aug 15;16(16):4345-8. Epub 2006 Jun 5.N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.